Search Results - healthcare:oncology

3 Results Sort By:
Selective Inhibitors of GSK3-beta
Technology Glycogen synthase kinase 3 (GSK3) is a ubiquitously expressed serine/threonine kinase that is being investigated clinically for a variety of therapeutic applications including CNS disorders, metabolic disorders and in dental health. Centrally, GSK3 is primarily responsible for aberrant phosphorylation of tau leading to pathologic...
Published: 1/31/2017   |   Inventor(s): Qing Xiao Li, Zhibin Liang
Keywords(s): Healthcare:Alzheimer’s Disease, Healthcare:Metabolic Diseases, Healthcare:Neurological Disorders, Healthcare:Oncology, Healthcare:Therapeutic, Therapeutic
Category(s): Chemistry, Healthcare, Therapeutic
Mesothelioma Biomarker
Malignant mesothelioma, which is associated with asbestos or erionite exposure, is an aggressive and lethal cancer of the mesothelium, the protective lining that covers many internal organs and is most commonly found in the lungs. The inventors have discovered that misregulation of a protein called High Mobility Group Box 1 (HMGB1) is linked to mes...
Published: 5/29/2015   |   Inventor(s): Haining Yang, Michele Carbone, Harvey Pass
Keywords(s): Diagnostic:Marker, Healthcare:Diagnostic Tool, Healthcare:Oncology, Screening:Detection
Category(s): Healthcare, Diagnostic, Diagnostic, Therapeutic
A novel Stat3 inhibitor that suppresses growth, viability, survival and migration of human breast and glioma cells in vitro
Researchers have discovered a new chemical compound that blocks the cancer causing biological molecule called Stat3, and by doing so controls growth and existence of human cancer cells. The compound strongly inhibits the activated form of Stat3, and consequently attenuates Stat3 functions in cancer cells. Accordingly, treatment of human breast canc...
Published: 4/10/2013   |   Inventor(s): James Turkson, Patrick Gunning, Sina Haftchenary
Keywords(s): Healthcare:Oncology
Category(s): Healthcare, Therapeutic
© 2018. All Rights Reserved. Powered by Inteum